Bentham Science Logo

Track Your Manuscript:


Current Pharmaceutical Design

Volume 28, 46 Issues, 2022
ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)
This journal supports open access

Contents

Current Pharmaceutical Design , Volume 19 - Number 18




Targeting the Ubiquitin E1 as a Novel Anti-Cancer Strategy

, 19(18): 3201 - 3209

Wei Xu, Julie L. Lukkarila, Sara R. da Silva, Stacey-Lynn Paiva, Patrick T. Gunning and Aaron D. Schimmer


DOI: 10.2174/1381612811319180004


Cdc20: A Potential Novel Therapeutic Target for Cancer Treatment

, 19(18): 3210 - 3214

Zhiwei Wang, Lixin Wan, Jiateng Zhong, Hiroyuki Inuzuka, Pengda Liu, Fazlul H. Sarkar and Wenyi Wei


DOI: 10.2174/1381612811319180005











An Update of Radiolabeled Bombesin Analogs for Gastrin-Releasing Peptide Receptor Targeting

, 19(18): 3329 - 3341

Zilin Yu, Hildo J. K. Ananias, Giuseppe Carlucci, Hilde D. Hoving, Wijnand Helfrich, Rudi A.J.O. Dierckx, Fan Wang, Igle J. de Jong and Philip H. Elsinga


DOI: 10.2174/1381612811319180015




Editor-in-Chief

Alessandro Antonelli
(14789 citations)
Department of Clinical and Experimental Medicine
Laboratory of Primary Human Cells
University of Pisa
Pisa
(Italy)
Biography
View Full Editorial Board

Nobel Laureate on Editorial Board

Andrew V. Schally
(USA)

COPE Compliant

Cope Logo

Advertisement

Mechanisms-of-Metabolic-Disorders-(MMD)

Related Journals

Related eBooks

eBooks Catalog